End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
3.82 EUR | +8.22% | -6.49% | -54.64% |
05-15 | Earnings Flash (BFRI) BIOFRONTERA Reports Q1 Revenue $7.9M, vs. Street Est of $10.9M | MT |
04-30 | Biofrontera AG Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Sales 2022 | 25.74M 27.87M 38.15M | Sales 2023 | 32.25M 34.92M 47.8M | Capitalization | 25.59M 27.7M 37.92M |
---|---|---|---|---|---|
Net income 2022 | -44M -47.64M -65.21M | Net income 2023 | - 0 0 | EV / Sales 2022 | 3.59 x |
Net cash position 2022 | 4.88M 5.28M 7.23M | Net cash position 2023 | 1.93M 2.09M 2.87M | EV / Sales 2023 | 0.73 x |
P/E ratio 2022 |
-1.98
x | P/E ratio 2023 |
-40.1
x | Employees | 92 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 32.4% |
Latest transcript on Biofrontera AG
1 day | +8.22% | ||
1 week | -6.49% | ||
Current month | -48.03% | ||
1 month | -47.43% | ||
3 months | -50.16% | ||
6 months | -64.05% | ||
Current year | -54.64% |
Managers | Title | Age | Since |
---|---|---|---|
Director of Finance/CFO | 55 | 22-09-11 | |
Anke zur Muehlen
IRO | Public Communications Contact | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | - | 21-12-13 | |
Heikki Lanckriet
BRD | Director/Board Member | 46 | 21-12-13 |
Helge Lubenow
CHM | Chairman | 56 | 21-12-13 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-22 | 3.82 | +8.22% | 579 |
24-05-21 | 3.53 | +1.73% | 3 |
24-05-20 | 3.47 | -1.14% | 156 |
24-05-17 | 3.51 | -1.40% | 109 |
24-05-16 | 3.56 | -12.85% | 928 |
End-of-day quote Xetra, May 21, 2024
More quotesQuarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-54.64% | 11.65M | |
+37.74% | 723B | |
+32.22% | 598B | |
-2.07% | 364B | |
+20.25% | 331B | |
+2.99% | 288B | |
+16.60% | 244B | |
+9.77% | 210B | |
-5.15% | 208B | |
+7.43% | 169B |
- Stock Market
- Equities
- B8FK Stock